An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab Treatment For Type 1 ROP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
- Status
- UNKNOWN
- Phase
- N/A
ONO-4538 Phase II Rollover Study (ONO-4538-98)
- Status
- RECRUITING
- Phase
- PHASE2
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
- Status
- COMPLETED
- Phase
- PHASE3
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
- Status
- TERMINATED
- Phase
- PHASE2